Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,168 | 73 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $213.32 | 14 | $0 (2024) |
| Novo Nordisk Inc | $198.45 | 12 | $0 (2024) |
| Astellas Pharma US Inc | $170.51 | 13 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $161.88 | 12 | $0 (2023) |
| Boston Scientific Corporation | $119.96 | 1 | $0 (2023) |
| GlaxoSmithKline, LLC. | $90.56 | 7 | $0 (2018) |
| Lilly USA, LLC | $43.58 | 3 | $0 (2024) |
| Abbott Laboratories | $43.25 | 2 | $0 (2024) |
| Amgen Inc. | $28.69 | 2 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $21.30 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $150.28 | 9 | Novo Nordisk Inc ($46.36) |
| 2023 | $206.18 | 6 | Boston Scientific Corporation ($119.96) |
| 2022 | $102.60 | 6 | AstraZeneca Pharmaceuticals LP ($70.03) |
| 2021 | $95.84 | 7 | AstraZeneca Pharmaceuticals LP ($35.65) |
| 2020 | $47.67 | 4 | Novo Nordisk Inc ($12.60) |
| 2019 | $175.43 | 11 | Astellas Pharma US Inc ($64.38) |
| 2018 | $220.55 | 17 | PFIZER INC. ($65.77) |
| 2017 | $169.10 | 13 | Astellas Pharma US Inc ($50.89) |
All Payment Transactions
73 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/25/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: Oncology | ||||||
| 10/23/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: Diabetes Care | ||||||
| 09/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Diabetes | ||||||
| 08/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: DIABETES | ||||||
| 06/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Diabetes | ||||||
| 04/22/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Diabetes | ||||||
| 04/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Diabetes | ||||||
| 08/17/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/11/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: Diabetes Care | ||||||
| 08/09/2023 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Neuroscience | ||||||
| 04/20/2023 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Neuroscience | ||||||
| 03/10/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/25/2023 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $119.96 | General |
| Category: WATCHMAN_IC | ||||||
| 12/06/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/18/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/12/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/02/2022 | PFIZER INC. | PREVNAR 20 (Biological), PAXLOVID | Food and Beverage | In-kind items and services | $32.57 | General |
| Category: VACCINES | ||||||
| 04/29/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/04/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/09/2021 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $12.49 | General |
| 11/17/2021 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: VACCINES | ||||||
| 11/17/2021 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $12.01 | General |
| Category: VACCINES | ||||||
| 09/10/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.58 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,013 | 2,141 | $400,170 | $155,438 |
| 2022 | 21 | 1,160 | 2,345 | $415,714 | $153,913 |
| 2021 | 20 | 1,106 | 2,246 | $390,319 | $157,103 |
| 2020 | 22 | 1,190 | 2,308 | $369,269 | $138,449 |
All Medicare Procedures & Services
81 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 246 | 1,033 | $261,349 | $88,397 | 33.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 79 | 79 | $25,122 | $22,339 | 88.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 178 | 178 | $45,746 | $21,739 | 47.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 97 | 154 | $27,412 | $9,403 | 34.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 38 | 38 | $6,384 | $2,730 | 42.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 79 | 79 | $6,083 | $2,304 | 37.9% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 60 | 93 | $6,045 | $1,484 | 24.5% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 21 | 22 | $3,850 | $1,323 | 34.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 42 | 42 | $3,234 | $1,225 | 37.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 23 | 116 | $5,452 | $1,158 | 21.2% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 25 | 58 | $1,972 | $940.76 | 47.7% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 15 | 16 | $1,648 | $589.20 | 35.8% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 12 | 15 | $1,455 | $519.30 | 35.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 47 | 52 | $1,716 | $508.54 | 29.6% |
| 73502 | X-ray of hip, 2-3 views | Office | 2023 | 11 | 14 | $980.00 | $348.27 | 35.5% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 14 | 18 | $684.00 | $291.60 | 42.6% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 15 | 92 | $828.00 | $108.76 | 13.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 11 | 42 | $210.00 | $30.06 | 14.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 265 | 987 | $249,774 | $87,404 | 35.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 201 | 201 | $51,657 | $24,950 | 48.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 174 | 366 | $65,148 | $23,946 | 36.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 60 | 60 | $7,842 | $4,106 | 52.4% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 44 | 57 | $5,151 | $1,992 | 38.7% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 73 | 121 | $7,865 | $1,936 | 24.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 64 | 64 | $4,928 | $1,796 | 36.4% |
About Dr. Michael Burton, MD
Dr. Michael Burton, MD is a Family Medicine healthcare provider based in Hickory, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083693980.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Burton, MD has received a total of $1,168 in payments from pharmaceutical and medical device companies, with $150.28 received in 2024. These payments were reported across 73 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,168).
As a Medicare-enrolled provider, Burton has provided services to 4,469 Medicare beneficiaries, totaling 9,040 services with total Medicare billing of $604,904. Data is available for 4 years (2020–2023), covering 81 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Hickory, NC
- Active Since 01/10/2006
- Last Updated 03/09/2016
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1083693980
Products in Payments
- FARXIGA (Drug) $149.39
- WATCHMAN Access System (Device) $119.96
- MYRBETRIQ (Drug) $107.23
- Ozempic (Drug) $87.66
- CHANTIX (Drug) $71.87
- ANORO (Drug) $62.91
- PREVNAR 20 (Biological) $62.66
- PREVNAR - 13 (Biological) $57.74
- FREESTYLE LIBRE 3 (Device) $43.25
- Vesicare (Drug) $38.70
- JARDIANCE (Drug) $35.29
- EMGALITY (Drug) $29.59
- BREO (Drug) $27.65
- Victoza (Drug) $25.83
- ELIQUIS (Drug) $21.05
- Prolia (Biological) $17.11
- VYVANSE (Drug) $16.09
- VOQUEZNA (Drug) $13.63
- Cologuard Collection Kit (Device) $13.61
- Tresiba (Drug) $12.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Hickory
Jonathan Wilson, Do, DO
Family Medicine — Payments: $31,125
Dr. Michael Desantis, M.d, M.D
Family Medicine — Payments: $12,291
David Duralia, M.d, M.D
Family Medicine — Payments: $11,991
Dr. Mary Britton, M.d, M.D
Family Medicine — Payments: $8,725
Robert Lee, Md, MD
Family Medicine — Payments: $8,629
Dr. Gregory Brooks, Md, MD
Family Medicine — Payments: $8,580